Trilostane Treatment of a Dog with Functional Adrenocortical Neoplasia

    J. M. Eastwood, Clive Elwood, Karyl J. Hurley
    Studysummary In this case study, medical management with trilostane improved clinical signs and normalized serum chemistry in a dog diagnosed with adrenal-dependent hyperadrenocorticism over 80 weeks of treatment.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on onlinelibrary.wiley.com →
    Discuss this study in the Community →

    Research cited in this study 2

    1. Trilostane Treatment of 78 Dogs With Pituitary-Dependent Hyperadrenocorticism Veterinary record/˜The œveterinary record · 2002
    2. Results of Clinical Examinations, Laboratory Tests, and Ultrasonography in Dogs with Pituitary-Dependent Hyperadrenocorticism Treated with Trilostane American journal of veterinary research · 2002